Accès gratuit
Numéro
Med Sci (Paris)
Volume 31, Novembre 2015
Les Cahiers de Myologie
Page(s) 20 - 27
Section Mise au point
DOI https://doi.org/10.1051/medsci/201531s306
Publié en ligne 6 novembre 2015
  1. Amouri R, Driss A, Murayama K, et al. Allelic heterogeneity of GNE gene mutation in two Tunisian families with autosomal recessive inclusion body myopathy. Neuromuscul Disord 2005 ; 15 : 361–363. [CrossRef] [PubMed] [Google Scholar]
  2. Argov Z. GNE myopathy: a personal trip from bedside observation to therapeutic trials. Acta Myol 2014 ; 33 : 107–110. [PubMed] [Google Scholar]
  3. Béhin A, Dubourg O, Laforêt P, et al. Distal myopathy due to mutations of GNE gene: clinical spectrum and diagnosis. Rev Neurol (Paris) 2008 ; 164 : 434–443. [CrossRef] [PubMed] [Google Scholar]
  4. Chamova T, Guergueltcheva V, Gospodinova M, et al. GNE myopathy in Roma patients homozygous for the p. I618T founder mutation. Neuromuscul Disord 2015 ; 25 : 713–718. [CrossRef] [PubMed] [Google Scholar]
  5. Chaouch A, Brennan KM, Hudson J, et al. Two recurrent mutations are associated with GNE myopathy in the North of Britain. J Neurol Neurosurg Psychiatry 2014 ; 85 : 1359–1365. [CrossRef] [PubMed] [Google Scholar]
  6. Eisenberg I, Avidan N, Potikha T, et al. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet 2001 ; 29 : 83–87. [CrossRef] [PubMed] [Google Scholar]
  7. Haghighi A, Nafissi S, Qurashi A, et al. Genetics of GNE myopathy in the non-Jewish Persian population. Eur J Hum Genet 2015 May 13. doi: 10.1038/ejhg.2015.78 [Google Scholar]
  8. Huizing M, Carrillo-Carrasco N, Malicdan MC, et al. GNE myopathy: new name and new mutation nomenclature. Neuromuscul Disord 2014 ; 24 : 387–389. [CrossRef] [PubMed] [Google Scholar]
  9. Kayashima T, Matsuo H, Satoh A, et al. Nonaka myopathy is caused by mutations in the UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase gene (GNE). J Hum Genet 2002 ; 47 : 77–79. [CrossRef] [PubMed] [Google Scholar]
  10. Khademian H, Mehravar E, Urtizberea J, et al. Prevalence of GNE p. M712T and hereditary inclusion body myopathy (HIBM) in Sangesar population of Northern Iran. Clin Genet 2013 ; 84 : 589–592. [CrossRef] [PubMed] [Google Scholar]
  11. Krause S, Hinderlich S, Amsili S, et al. Localization of UDP-GlcNAc 2-epimerase/ManAckinase (GNE) in the Golgi complex and the nucleus of mammalian cells. Exp Cell Res 2005 ; 304 : 365–379. [CrossRef] [PubMed] [Google Scholar]
  12. Kurochkina N, Yardeni T, Huizing M. Molecular modeling of the bifunctional enzyme UDP-GlcNAc 2-epimerase/ManNAc kinase and predictions of structural effects of mutations associated with HIBM and sialuria. Glycobiology 2010 ; 20 : 322–337. [CrossRef] [PubMed] [Google Scholar]
  13. Malicdan MC, Noguchi S, Nonaka I, et al. A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. Hum Mol Genet 2007 ; 16 : 2669–2682. [CrossRef] [PubMed] [Google Scholar]
  14. Malicdan MC, Noguchi S, Nishino I. A preclinical trial of sialic acid metabolites on distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy, a sugar-deficient myopathy: a review. Ther Adv Neurol Disord 2010 ; 3 : 127–135. [CrossRef] [PubMed] [Google Scholar]
  15. Mori-Yoshimura M, Oya Y, Hayashi YK, et al. Respiratory dysfunction in patients severely affected by GNE myopathy (distal myopathy with rimmed vacuoles). Neuromuscul Disord 2013 ; 23 : 84–88. [CrossRef] [PubMed] [Google Scholar]
  16. Mitrani-Rosenbaum S, Yakovlev L, Becker Cohen M, et al. Sustained expression and safety of human GNE in normal mice after gene transfer based on AAV8 systemic delivery. Neuromuscul Disord 2012 ; 22 : 1015–1024. [CrossRef] [PubMed] [Google Scholar]
  17. Malicdan MC, Noguchi S, Hayashi YK, et al. Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model. Nat Med 2009 ; 15 : 690–695. [CrossRef] [PubMed] [Google Scholar]
  18. Nalini A, Gayathri N, Nishino I, et al. GNE myopathy in India. Neurol India 2013 ; 61 : 371–374. [CrossRef] [PubMed] [Google Scholar]
  19. Nishino I, Carrillo-Carrasco N, Argov Z. GNE myopathy: current update and future therapy. J Neurol Neurosurg Psychiatry 2015 ; 86 : 385–392. [CrossRef] [PubMed] [Google Scholar]
  20. Nemunaitis G, Jay CM, Maples PB, et al. Hereditary inclusion body myopathy: single patient response to intravenous dosing of GNE gene lipoplex. Hum Gene Ther 2011 ; 22 : 1331–1341. [CrossRef] [PubMed] [Google Scholar]
  21. Park YE, Kim HS, Choi ES, et al. Limb-girdle phenotype is frequent in patients with myopathy associated with GNE mutations. J Neurol Sci 2012 ; 321 : 77–81. [CrossRef] [PubMed] [Google Scholar]
  22. Reinke SO, Lehmer G, Hinderlich S, et al. Regulation and pathophysiological implications of UDP-GlcNAc 2-epimerase/ManNAc kinase (GNE) as the key enzyme of sialic acid biosynthesis. Biol Chem 2009 ; 390 : 591–599. [CrossRef] [PubMed] [Google Scholar]
  23. Sim JE, Park HJ, Shin HY, et al. Clinical characteristics and molecular genetic analysis of Korean patients with GNE myopathy. Yonsei Med J 2013 ; 54 : 578–582. [CrossRef] [PubMed] [Google Scholar]
  24. Sparks S, Rakocevic G, Joe G, et al. Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study. BMC Neurol 2007 ; 7 : 3. [PubMed] [Google Scholar]
  25. Tasca G, Ricci E, Monforte M, et al. Muscle imaging findings in GNE myopathy. J Neurol 2012 ; 259 : 1358–1365. [CrossRef] [PubMed] [Google Scholar]
  26. Tong Y, Tempel W, Nedyalkova L, et al. Crystal structure of the N-acetylmannosamine kinase domain of GNE. PLoS One 2009 ; 4 : e7165. [CrossRef] [PubMed] [Google Scholar]
  27. Yardeni T, Choekyi T, Jacobs K, et al. Identification, tissue distribution, and molecular modeling of novel human isoforms of the key enzyme in sialic acid synthesis, UDP-GlcNAc 2-epimerase/ManNAc kinase. Biochemistry 2011 ; 50 : 8914–8925. [CrossRef] [PubMed] [Google Scholar]
  28. Yonekawa T, Malicdan MC, Cho A, et al. Sialyllactose ameliorates myopathic phenotypes in symptomatic GNE myopathy model mice. Brain 2014 ; 137 : 2670–2679. [CrossRef] [PubMed] [Google Scholar]
  29. Zhao J, Wang Z, Hong D, et al. Mutational spectrum and clinical features in 35 unrelated mainland Chinese patients with GNE myopathy. J Neurol Sci 2015 ; 354 : 21–26. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.